Insider Trading activities of Replimune Group, Inc. (REPL)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Replimune Group, Inc. (REPL) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Replimune Group, Inc. since year 2005. Table 2 shows the detailed insider transactions of Replimune Group, Inc. since 2005. The reporting company's ticker symbol is REPL. The reporting company's CIK number is 1737953.
The total value of stock buying since 2005 is $33,565,200.
The total value of stock sales since 2005 is $5,106,099.
The total value of stock option exercises since 2005 is $152,250.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Replimune Group, Inc. (REPL).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-11 1,320,000 $17,965,200 200,000 $3,403,600 0 $0
2019-10 0 $0 50,000 $850,000 0 $0
2019-09 0 $0 50,000 $852,499 0 $0
2018-12 0 $0 0 $0 87,000 $152,250
2018-07 1,040,000 $15,600,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Replimune Group, Inc. insiders (REPL)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-11-18 Rhodes Jason P (Director) Buy 1,100,000 13.61 14,971,000
2019-11-18 Stampacchia Otello Buy 220,000 13.61 2,994,200
2019-11-06 Love Colin (Chief Operating Officer) Sale 22,500 17.01 382,725
2019-11-06 Coffin Robert (President and CEO) Sale 48,500 17.01 824,985
2019-11-06 Astley-sparke Philip (Executive Chairman) Sale 29,000 17.01 493,290
2019-11-04 Love Colin (Chief Operating Officer) Sale 22,500 17.03 383,085
2019-11-04 Coffin Robert (President and CEO) Sale 48,500 17.03 825,761
2019-11-04 Astley-sparke Philip (Executive Chairman) Sale 29,000 17.03 493,754
2019-10-31 Love Colin (Chief Operating Officer) Sale 11,250 17.00 191,250
2019-10-31 Coffin Robert (President and CEO) Sale 24,250 17.00 412,250
2019-10-31 Astley-sparke Philip (Executive Chairman) Sale 14,500 17.00 246,500
2019-09-23 Love Colin (Chief Operating Officer) Sale 11,250 17.05 191,812
2019-09-23 Coffin Robert (President and CEO) Sale 24,250 17.05 413,462
2019-09-23 Astley-sparke Philip (Executive Chairman) Sale 14,500 17.05 247,225
2018-12-13 Esposito Pamela (Chief Business Officer) Option Ex 87,000 1.75 152,250
2018-07-24 Forbion Capital Fund Iii Cooperatief U.a. (10% Owner) Buy 133,333 15.00 1,999,995
2018-07-24 Slootweg Hugo Alexander (Director) Buy 133,333 15.00 1,999,995
2018-07-24 Paster Anne-mari (10% Owner) Buy 266,667 15.00 4,000,005
2018-07-24 Koppel Adam (Director) Buy 500,000 15.00 7,500,000
2018-07-24 Slattery Joseph P (Director) Buy 6,667 15.00 100,005

Insider trading activities including stock purchases, stock sales, and option exercises of REPL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Replimune Group, Inc. (symbol REPL, CIK number 1737953) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month